Sutton Wealth Advisors Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Sutton Wealth Advisors Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$23.68 - $38.51 $94 - $154	-4 Closed	0 $0
Q4 2022 Nov 07, 2023	SELL	$28.0 - $40.56 $224 - $324	-8 Reduced 66.67%	4 $162,000
Q3 2022 Nov 07, 2023	BUY	$29.63 - $48.31 $355 - $579	12 New	12 $397,000
Q1 2022 Nov 07, 2023	SELL	$39.62 - $69.97 $475 - $839	-12 Closed	0 $0
Q4 2021 Nov 07, 2023	BUY	$58.09 - $82.51 $697 - $990	12 New	12 $796,000

Q1 2020 Nov 07, 2023	SELL	$20.56 - $63.12 $2,056 - $6,312	-100 Reduced 66.67%	50 $1.44 Million
Q4 2019 Nov 07, 2023	SELL	$28.14 - $73.01 $41,281 - $107,105	-1,467 Reduced 90.72%	150 $9.52 Million
Q2 2019 Nov 06, 2023	BUY	$17.43 - $28.82 $28,184 - $46,601	1,617 New	1,617 $42.9 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.